Register for free to
view the full innovation profile.
An immunocapture device that specifically captures bladder cancer cells from urine for analysis.
About
BACKGROUND Bladder cancer is on average the 9th most common of all cancers (the chance of developing bladder cancer is 1 in 27 for men and 1 in 89 for women), and the most expensive to treat from diagnosis to death because of its particularly high recurrence rate (
Key Benefits
• Non-invasive • No pre-processing of urine sample required • Significant improvement over current cytology approaches
Applications
This technology is relevant for the biomedical point of care diagnostic market.